[Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis].

Funke, Manuela; Geiser, Thomas (2016). [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis]. Therapeutische Umschau, 73(1), pp. 25-29. Huber 10.1024/0040-5930/a000751

Full text not available from this repository.

Recent studies have shown efficacy to slow the decrease of forced vital capacity in patients with idiopathic pulmonary fibrosis. This summary refers to recent anti-fibrotic medications and describes current studies, indication for treatment and side effects, as well as discusses open questions of treatment.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Funke, Manuela, Geiser, Thomas (A)

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0040-5930

Publisher:

Huber

Language:

German

Submitter:

Rahel Holderegger

Date Deposited:

22 Mar 2017 15:28

Last Modified:

29 Mar 2023 23:35

Publisher DOI:

10.1024/0040-5930/a000751

PubMed ID:

26884217

URI:

https://boris.unibe.ch/id/eprint/93081

Actions (login required)

Edit item Edit item
Provide Feedback